Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 6, 2014, Pages 1265-1272

  Han, Jung Mi ^a   Jo, An Na ^a   Lee, Seung Min ^a   Bae, Hyun Suk ^a   Jun, Dae Won ^b   Cho, Yong Kyun ^c   Suk, Ki Tae ^e   Yoon, Jai Hoon ^e   Ahn, Sang Bong ^d   Cho, Yong Jin ^f   Kim, Seong Woo ^f   Jang, Eun Chul ^f  

^a Sungshin Women's University   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Eulji University   (South Korea)

^e Hallym University College of Medicine   (South Korea)

^f Soonchunhyang University College of Medicine   (South Korea)

Author keywords

NAFLD; Nuts and seeds; Vegetables; Vitamin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CALCIUM; CARBOHYDRATE; CHOLESTEROL; CYANOCOBALAMIN; FAT; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANGANESE; NICOTINIC ACID; PHOSPHORUS; POLYUNSATURATED FATTY ACID; POTASSIUM; PROTEIN; PYRIDOXINE; RETINOL; RIBOFLAVIN; SATURATED FATTY ACID; SODIUM; THIAMINE; TRIACYLGLYCEROL; VITAMIN D; VITAMIN K GROUP; ZINC; OMEGA 3 FATTY ACID;

ABDOMINAL OBESITY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEAN; BODY MASS; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DAIRY PRODUCT; DIET RESTRICTION; DIETARY INTAKE; EGG; FEMALE; FIBER; FISH; FRUIT; GENDER; GLUCOSE BLOOD LEVEL; GRAIN; HEALTH BEHAVIOR; HUMAN; INTERVIEW; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MEAT; MILK; MUSHROOM; NONALCOHOLIC FATTY LIVER; NUT; PLANT SEED; POTATO; PRIORITY JOURNAL; RISK ASSESSMENT; SEAWEED; SMOKING; SPICE; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND; VEGETABLE; VITAMIN INTAKE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; DIET; EPIDEMIOLOGY; FOOD; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK; SOUTH KOREA; YOUNG ADULT;

ADULT; AGED; ASCORBIC ACID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIET; FATTY ACIDS, OMEGA-3; FEMALE; FOLIC ACID; FOOD; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTS; REPUBLIC OF KOREA; RISK; SEEDS; VEGETABLES; VITAMIN K; YOUNG ADULT;

EID: 84900552281     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12520     Document Type: Article

References (30)

1. Lee JY, Kim KM, Lee SG etal. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J. Hepatol. 2007; 47: 239-244.
2. Yasutake K, Nakamuta M, Shima Y etal. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand. J. Gastroenterol. 2009; 44: 471-477.
3. Nakamuta M, Kohjima M, Higuchi N etal. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Int. J. Mol. Med. 2008; 22: 663-667.
4. McCarthy EM, Rinella ME. The role of diet and nutrient composition in nonalcoholic Fatty liver disease. J. Acad. Nutr. Diet. 2012; 112: 401-409.
5. Pagadala MF, McCullough AJ. Non-alcoholic fatty liver disease and obesity: not all about body mass index. Am. J. Gastroenterol. 2012; 107: 1859-1861.
6. Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, Camilo ME. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin. Nutr. 2006; 25: 816-823.
7. Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann. Hepatol. 2009; 8 (Suppl. 1): S4-8.
8. Wadden TA, Butryn ML. Behavioral treatment of obesity. Endocrinol. Metab. Clin. North Am. 2003; 32: 981-1003, x.
9. Franz MJ, VanWormer JJ, Crain AL etal. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J. Am. Diet. Assoc. 2007; 107: 1755-1767.
10. Gillies CL, Abrams KR, Lambert PC etal. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007; 334: 299.
11. Fabricatore AN. Behavior therapy and cognitive-behavioral therapy of obesity: is there a difference? J. Am. Diet. Assoc. 2007; 107: 92-99.
12. Musso G, Gambino R, De Michieli F etal. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37: 909-916.
13. Lee MJ, Popkin BM, Kim S. The unique aspects of the nutrition transition in South Korea: the retention of healthful elements in their traditional diet. Public Health Nutr. 2002; 5: 197-203.
14. Willett W. Nutritional Epidemiology, 3rd edn. New York: Oxford University Press, 2012.
15. Hermsdorff H, Puchau B, Volp ACP etal. Dietary total antioxidant capacity is inversely related to central adiposity as well as to metabolic and oxidative stress markers in healthy young adults. Ann. Nutr. Metab. 2011; 8: 1-8.
16. Shi L, Liu ZW, Li Y etal. The prevalence of nonalcoholic fatty liver Disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed. Environ. Sci. 2012; 25: 383-391.
17. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J. Pediatr. 2000; 136: 734-738.
18. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 2003; 98: 2485-2490.
19. De Feo E, Cefalo C, Arzani D etal. A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease. Mol. Biol. Rep. 2012; 39: 7381-7388.
20. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R etal. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J. Hepatol. 2007; 47: 711-717.
21. Assy N, Nasser G, Kamayse I etal. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can. J. Gastroenterol. 2008; 22: 811-816.
22. Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J. Gastroenterol. 2010; 16: 2579-2588.
23. Allard JP, Aghdassi E, Mohammed S etal. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J. Hepatol. 2008; 48: 300-307.
24. Ricci G, Canducci E, Pasini V etal. Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease. Nutrition 2011; 27: 672-676.
25. Spadaro L, Magliocco O, Spampinato D etal. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig. Liver Dis. 2008; 40: 194-199.
26. Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J. Gastroenterol. 2008; 14: 6395-6400.
27. Capanni M, Calella F, Biagini M etal. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment. Pharmacol. Ther. 2006; 23: 1143-1151.
28. Hatzitolios A, Savopoulos C, Lazaraki G etal. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia. Indian J. Gastroenterol. 2004; 23: 131-134.
29. Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2008; 42: 413-418.
30. Vega GL, Chandalia M, Szczepaniak LS, Grundy SM. Effects of N-3 fatty acids on hepatic triglyceride content in humans. J. Investig. Med. 2008; 56: 780-785.